Change search
ReferencesLink to record
Permanent link

Direct link
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
Show others and affiliations
2015 (English)In: Anticancer Research, ISSN 0250-7005, E-ISSN 1791-7530, Vol. 35, no 5Article in journal (Refereed) Published
Abstract [en]

Malignant pleural mesothelioma (MPM) is a rare but aggressive malignancy mainly localized to the pleura. Malignant mesothelioma grows highly invasive into surrounding tissue and has a low tendency to metastasize. The median overall survival (OS) of locally advanced or metastatic disease without treatment is 4-13 months but, during recent years, improvement in survival has been achieved since treatment for patients with mesothelioma has improved with better palliative care, systemic medical treatment, surgery and improved diagnostics methods. The present review aims at describing available data from randomized trials considering systemic medical treatment for this patient category.

Place, publisher, year, edition, pages
2015. Vol. 35, no 5
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-120020PubMedID: 25964522OAI: diva2:926213
Available from: 2016-05-04 Created: 2016-05-04 Last updated: 2016-05-04

Open Access in DiVA

No full text

In the same journal
Anticancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 5 hits
ReferencesLink to record
Permanent link

Direct link